Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7017773 drug-drug interaction study with rifampicin or gemfibrozil in healthy adults
NL-OMON49446Completed
- Sponsor
- Roche
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of alogabat in Autism Spectrum Disorder (ASD), sponsored by Roche. Started Jul 2020; status: completed.
02
Drugs
alogabat
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NL-OMON49446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49446.